Literature DB >> 14754955

A cautionary tale about supplemental oxygen: the albatross of neonatal medicine.

William A Silverman1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 14754955     DOI： 10.1542/peds.113.2.394

Source DB:  PubMed          Journal:  Pediatrics        ISSN： 0031-4005            Impact factor:   7.124


× No keyword cloud information.
  17 in total

Review 1.  Pharmacologic interventions for the prevention and treatment of retinopathy of prematurity.

Authors:  Kay D Beharry; Gloria B Valencia; Douglas R Lazzaro; Jacob V Aranda
Journal:  Semin Perinatol       Date:  2016-01-29       Impact factor: 3.300

2.  Variation in rates of severe retinopathy of prematurity among neonatal intensive care units in the Australian and New Zealand Neonatal Network.

Authors:  B A Darlow; J L Hutchinson; J M Simpson; D J Henderson-Smart; D A Donoghue; N J Evans
Journal:  Br J Ophthalmol       Date:  2005-12       Impact factor: 4.638

3.  Severe retinopathy of prematurity in infants <30 weeks' gestation in New South Wales and the Australian Capital Territory from 1992 to 2002.

Authors:  D A Todd; A Wright; J Smith
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2007-01-24       Impact factor: 5.747

Review 4.  Optimum oxygen therapy in preterm babies.

Authors:  W Tin; S Gupta
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2007-03       Impact factor: 5.747

5.  Very long apnea events in preterm infants.

Authors:  Mary A Mohr; Brooke D Vergales; Hoshik Lee; Matthew T Clark; Douglas E Lake; Anne C Mennen; John Kattwinkel; Robert A Sinkin; J Randall Moorman; Karen D Fairchild; John B Delos
Journal:  J Appl Physiol (1985)       Date:  2014-12-30

6.  A physiologic reduced oxygen protocol decreases the incidence of threshold retinopathy of prematurity.

Authors:  Kenneth W Wright; David Sami; Lisa Thompson; Rangasamy Ramanathan; Roy Joseph; Sonal Farzavandi
Journal:  Trans Am Ophthalmol Soc       Date:  2006

7.  Algorithms that eliminate the effects of calibration artefact and trial-imposed offsets of Masimo oximeter in BOOST-NZ trial.

Authors:  Marina Zahari; Dominic Savio Lee; Brian Alexander Darlow
Journal:  J Clin Monit Comput       Date:  2015-08-18       Impact factor: 2.502

Review 8.  Manipulation of gene expression by oxygen: a primer from bedside to bench.

Authors:  Clyde J Wright; Phyllis A Dennery
Journal:  Pediatr Res       Date:  2009-07       Impact factor: 3.756

9.  Malpractice and the quality of care in retinopathy of prematurity (an American Ophthalmological Society thesis).

Authors:  James D Reynolds
Journal:  Trans Am Ophthalmol Soc       Date:  2007

Review 10.  Emerging treatments for retinopathy of prematurity.

Authors:  Iason S Mantagos; Deborah K Vanderveen; Lois E H Smith
Journal:  Semin Ophthalmol       Date:  2009 Mar-Apr       Impact factor: 1.975
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.